On August 26, 2024, Novo Nordisk A/S announced its ongoing share repurchase program initiated on August 7, 2024, planning to buy back B shares worth up to DKK 20 billion over 12 months, having repurchased 11.6 million shares for a total of DKK 10.2 billion as of August 23, 2024.